| mRNA |
EKB-569 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
4e-07 |
| mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
0.28 |
5e-07 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
8e-07 |
| mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
0.26 |
1e-06 |
| mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-06 |
| mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
1e-05 |
| mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.31 |
3e-05 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-05 |
| mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-05 |